CLINICAL_TRIALS ClinicalTrials.gov record update

Safety, Tolerability, and Patient Satisfaction of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment by Rapid Push in Patients With Primary or Secondary Immunodeficiency (PID or SID)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04354129
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:56.421798+00:00
Published At: 2025-01-28T00:00:00+00:00
Record Updated At: 2025-01-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Primary Immune Deficiency Disorder", "Secondary Immune Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-01-28"
protocolSection.identificationModule.nctId: "NCT04354129"
protocolSection.identificationModule.officialTitle: "Safety, Tolerability, and Patient Satisfaction of 16.5% Subcutaneous Immunoglobulin (Cutaquig\u00ae) Treatment by Rapid Push in Patients With Primary or Secondary Immunodeficiency (PID or SID)"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.